Advertisement

The Scientist

» biotechnology

Most Recent

image: Biotech Buys Autoimmune Firm for $7B

Biotech Buys Autoimmune Firm for $7B

By | July 16, 2015

Celgene has purchased Receptos, developer of an experimental multiple sclerosis drug.

0 Comments

image: FDA OKs Herpes Blood Test

FDA OKs Herpes Blood Test

By | July 6, 2015

The US Food and Drug Administration approves Theranos’s fingerstick test for herpes.

0 Comments

image: CAR-T Therapies Get $1 Billion Boost

CAR-T Therapies Get $1 Billion Boost

By | July 1, 2015

The biotech firm Celgene inks a huge collaboration deal with Juno Therapeutics to develop and commercialize new cancer immunotherapies.

0 Comments

image: Celladon Shutters Its R&D

Celladon Shutters Its R&D

By | June 26, 2015

Biotech firm likely to pull the plug after its gene therapy product fails.

0 Comments

image: Week in Review: June 22–26

Week in Review: June 22–26

By | June 26, 2015

Neanderthal-human hybrid discovered; the neurobiology of fear behavior; and an insulin patch that responds to high glucose levels in mice

0 Comments

image: Organ-on-a-Chip Gets Big Pharma Boost

Organ-on-a-Chip Gets Big Pharma Boost

By | June 18, 2015

Johnson & Johnson agrees to use Emulate’s blood-clot device in three of its preclinical drug programs.

0 Comments

image: Optogenetics Meets CRISPR

Optogenetics Meets CRISPR

By | June 15, 2015

Researchers in Japan have developed a photoactivatable Cas9 nuclease to control CRISPR-based gene editing with the flip of a switch.

0 Comments

image: Synthetic Biology Entrepreneur Dies

Synthetic Biology Entrepreneur Dies

By | June 11, 2015

Austen Heinz, who founded Cambrian Genomics to custom print DNA and had grand ideas about designing organisms, has passed away at age 31.

0 Comments

image: Roche Snags Tumor Tester for $1B

Roche Snags Tumor Tester for $1B

By | January 13, 2015

The pharmaceutical company bought a majority stake in Foundation Medicine, a firm that develops personalized cancer-medicine diagnostics.

0 Comments

image: Pharma and Biotech Firms Hacked

Pharma and Biotech Firms Hacked

By | December 2, 2014

Cyberspies have broken into the e-mails of a number of publicly traded companies, most of which are in health care and pharmaceuticals.

0 Comments

Advertisement
LI-COR
LI-COR

Popular Now

  1. Most Earth-like Planet Found
  2. When Does a Smart Mouse Become Human?
  3. AAAAA Is for Arrested Translation
  4. Antibiotic Resistance Can Boost Bacterial Fitness
Advertisement
NeuroScientistNews
NeuroScientistNews
Advertisement
The Scientist